Early identification of glioma prognostic characteristics is of great clinical importance. This study aims to evaluate the feasibility of APT in the prediction of tumor grade, IDH mutation and MGMT promoter methylation status at 3 Tesla. A total of 50 patients were recruited. Results show that although APTw effect exhibits no substantial difference based on MGMT methylation status, it enables the discrimination of histopathological grade and IDH mutant status with AUCs higher than 0.88. The results suggest APTw is a valuable imaging biomarker for prediction of tumor prognostic parameters, that may benefit accurate diagnosis and prompt treatment decisions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords